Figures and Tables

From the following article:

VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model

Mimoun Azzouz, G. Scott Ralph, Erik Storkebaum, Lucy E. Walmsley, Kyriacos A. Mitrophanous, Susan M. Kingsman, Peter Carmeliet and Nicholas D. Mazarakis

Nature 429, 413-417(27 May 2004)

doi:10.1038/nature02544

BACK TO ARTICLE
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 1

EIAV vector-mediated gene transfer in vitro and in vivo.

Full size figure and legend (121K)
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 2

Effects of EIAV vector delivery of VEGF.

Full size figure and legend (88K)
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 3

VEGF gene therapy protects spinal and brainstem motor neurons in SOD1G93A transgenic mice.

Full size figure and legend (61K)
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

Figure 4

The effects of VEGF gene therapy five weeks after intramuscular injections of viral vectors.

Full size figure and legend (137K)
BACK TO ARTICLE